Related Experiment Videos
C9 deficiency in a patient with poststreptococcal glomerulonephritis
1Department of Pediatrics, Gunma University School of Medicine, Japan.
Pediatric Nephrology (Berlin, Germany)
|December 1, 1995
Summary
A child with congenital C9 deficiency presented with symptoms resembling Henoch-Schönlein purpura. Renal biopsy confirmed poststreptococcal glomerulonephritis (PSGN), highlighting diagnostic challenges in complement deficiencies.
Area of Science:
- Pediatric Nephrology
- Immunology
- Genetics
Background:
- Congenital complement deficiencies, such as C9 deficiency, can predispose individuals to infections and autoimmune conditions.
- Poststreptococcal glomerulonephritis (PSGN) is a common cause of acute kidney injury in children, often following a streptococcal infection.
- Henoch-Schönlein purpura (HSP) is a systemic vasculitis that can present with similar symptoms to PSGN, including abdominal pain, rash, and joint pain.
Observation:
- A 10-year-old girl with known congenital C9 deficiency presented with clinical manifestations suggestive of Henoch-Schönlein purpura.
- The patient experienced symptoms including palpable purpura and joint pain, which are characteristic of HSP.
- Despite the initial clinical presentation, laboratory findings and urinalysis were also considered.
Findings:
- Histological examination of a renal biopsy specimen was crucial for accurate diagnosis.
- The renal biopsy revealed characteristic features of poststreptococcal glomerulonephritis (PSGN).
- This finding indicated that the patient's symptoms were due to PSGN, not HSP, despite the underlying C9 deficiency.
Implications:
- This case underscores the importance of comprehensive diagnostic evaluation, including renal biopsy, in children with complement deficiencies presenting with nephritis-like symptoms.
- It highlights the potential for overlapping clinical features between different renal diseases, necessitating careful histological assessment.
- Understanding the interplay between complement deficiencies and infections like PSGN is vital for optimizing patient management and predicting outcomes.